SCHEMBL13601654

SCHEMBL13601654

CCCOC(=O)CCC(=O)N1CCN(C)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.51
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.51
ALDH1A1 P00352 2/20 0.50
SMN1; SMN2 Q16637 3/20 0.43
HTT P42858 1/20 0.43
GNAI3 P08754 3/20 0.41
GNAO1 P09471 3/20 0.41
GNAI1 P63096 3/20 0.41
RAB9A P51151 3/20 0.41
L3MBTL1 Q9Y468 3/20 0.41
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
HPGD P15428 1/20 0.40
NPC1 O15118 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
HTR1A P08908 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13601659 0.90 LMNA (0.49) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL13601661 0.88 HTR2C (0.51) TSHRLMNAPOLBALDH1A1GNAI3
SCHEMBL13601664 0.83 DNM1 (0.46) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL4685619 0.83 ALDH1A1 (0.46) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL17557992 0.81 HRH2 (0.47) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL13601626 0.81 NPC1 (0.57) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL12259096 0.80 GLA (0.54) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL19901120 0.80 TSHR (0.42) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL13601667 0.80 TSHR (0.42) TSHRLMNAPOLBALDH1A1SMN1; SMN2
SCHEMBL123476 0.79 THRB (0.48) TSHRLMNAALDH1A1SMN1; SMN2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed